Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Narges K, Tafreshi"'
Autor:
David L. Morse, Robert J. Gillies, Stephen R. Grobmyer, Josef Vagner, Bradford W. Carter, Dominique Abrahams, Alexis S. Lopez, Steven A. Enkemann, Mark C. Lloyd, Kellsey Bishop, Marilyn M. Bui, Narges K. Tafreshi
PDF file - 1.5MB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26b34c5b0fcc16566780c8f7dcb7c999
https://doi.org/10.1158/1078-0432.22445811
https://doi.org/10.1158/1078-0432.22445811
Autor:
David L. Morse, Robert J. Gillies, Stephen R. Grobmyer, Josef Vagner, Bradford W. Carter, Dominique Abrahams, Alexis S. Lopez, Steven A. Enkemann, Mark C. Lloyd, Kellsey Bishop, Marilyn M. Bui, Narges K. Tafreshi
Purpose: To develop targeted molecular imaging probes for the noninvasive detection of breast cancer lymph node metastasis.Experimental Design: Six cell surface or secreted markers were identified by expression profiling and from the literature as be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c43ab44166a913f307f9345c6bb7d8f
https://doi.org/10.1158/1078-0432.c.6520566.v1
https://doi.org/10.1158/1078-0432.c.6520566.v1
Autor:
David L. Morse, Robert J. Gillies, Josef Vagner, W. Bradford Carter, Stephen R. Grobmyer, Jongphil Kim, Amanda S. Huynh, Dominique Abrahams, Mark C. Lloyd, Marilyn M. Bui, Steven A. Enkemann, Narges K. Tafreshi
Pathologic axillary lymph node (ALN) status is an important prognostic factor for staging breast cancer. Currently, status is determined by histopathology following surgical excision of sentinel lymph node(s), which is an invasive, time consuming, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99233bae27f924f2c075511415a60a98
https://doi.org/10.1158/0008-5472.c.6503055.v1
https://doi.org/10.1158/0008-5472.c.6503055.v1
Autor:
David L. Morse, Robert J. Gillies, Josef Vagner, W. Bradford Carter, Stephen R. Grobmyer, Jongphil Kim, Amanda S. Huynh, Dominique Abrahams, Mark C. Lloyd, Marilyn M. Bui, Steven A. Enkemann, Narges K. Tafreshi
Supplementary Figures 1-4 from A Mammaglobin-A Targeting Agent for Noninvasive Detection of Breast Cancer Metastasis in Lymph Nodes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b179842476c8b9d907047b80060618b4
https://doi.org/10.1158/0008-5472.22390785.v1
https://doi.org/10.1158/0008-5472.22390785.v1
Autor:
Narges K. Tafreshi, Haitao Ji, Robert W. Engelman, Jordan N Reff, Zhen Wang, Thaddeus J. Wadas, Alberto Chiappori, Christopher J. Tichacek, David L. Morse, Ghassan El-Haddad, Darpan N. Pandya, Mikalai M. Budzevich, David Boulware, Jonathan R. Strosberg
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 48:3408-3421
There is significant interest in the development of targeted alpha-particle therapies (TATs) for treatment of solid tumors. The metal chelator-peptide conjugate, DOTA-TATE, loaded with the β-particle emitting radionuclide 177Lu ([177Lu]Lu-DOTA-TATE)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c91d6f8d22fa2108b214d602152c043
https://doi.org/10.1007/s00259-021-05315-1
https://doi.org/10.1007/s00259-021-05315-1
Publikováno v:
World Journal of Clinical Oncology
Triple-negative breast cancer (TNBC) is defined as a type of breast cancer with lack of expression of estrogen receptor, progesterone receptor and human epidermal growth factor 2 protein. In comparison to other types of breast cancer, TNBC characteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::009cb841a7805ecc039c86f7da3d24fc
https://doi.org/10.5306/wjco.v11.i4.169
https://doi.org/10.5306/wjco.v11.i4.169
Autor:
Michael L. Langsen, Robert W. Engelman, Michael L. Doligalski, Darpan N. Pandya, Mark L. McLaughlin, Narges K. Tafreshi, David L. Morse, HyunJoo Kil, Christopher J. Tichacek, Eduardo G. Moros, Thaddeus J. Wadas, Kenneth L. Gage, John A. Vallas, David Boulware, Nella C. Delva, Mikalai M. Budzevich
Publikováno v:
ACS Pharmacol Transl Sci
[Image: see text] Lipophilicity is explored in the biodistribution (BD), pharmacokinetics (PK), radiation dosimetry (RD), and toxicity of an internally administered targeted alpha-particle therapy (TAT) under development for the treatment of metastat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c127ceea470c3ba7b4f9e79b33c0f87b
https://pubmed.ncbi.nlm.nih.gov/33860213
https://pubmed.ncbi.nlm.nih.gov/33860213
Autor:
Narges K, Tafreshi, Darpan N, Pandya, Christopher J, Tichacek, Mikalai M, Budzevich, Zhen, Wang, Jordan N, Reff, Robert W, Engelman, David C, Boulware, Alberto A, Chiappori, Jonathan R, Strosberg, Haitao, Ji, Thaddeus J, Wadas, Ghassan, El-Haddad, David L, Morse
Publikováno v:
European journal of nuclear medicine and molecular imaging. 48(11)
There is significant interest in the development of targeted alpha-particle therapies (TATs) for treatment of solid tumors. The metal chelator-peptide conjugate, DOTA-TATE, loaded with the β-particle emitting radionuclide[[These results suggest sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::677e887c74e02cd62addb2ebdfbd61cc
https://pubmed.ncbi.nlm.nih.gov/33772332
https://pubmed.ncbi.nlm.nih.gov/33772332
Autor:
Robert W. Engelman, David L. Morse, Mikalai M. Budzevich, HyunJoo Kil, Mark L. McLaughlin, Kenneth L Gage, Michael L. Doligalski, Eduardo G. Moros, Christopher J. Tichacek, Narges K. Tafreshi, Thaddeus J. Wadas, Ariosto S. Silva
Publikováno v:
Molecular pharmaceutics. 17(11)
Targeted α particle therapy (TAT) is ideal for treating disease while minimizing damage to surrounding nontargeted tissues due to short path length and high linear energy transfer (LET). We developed a TAT for metastatic uveal melanoma, targeting th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55eb5220ddf1fc9defae19528b1a506c
https://pubmed.ncbi.nlm.nih.gov/32960613
https://pubmed.ncbi.nlm.nih.gov/32960613
Autor:
Daruka Mahadevan, Weihong Sun, Mikalai M. Budzevich, Marie Catherine Lee, Narges K. Tafreshi, David L. Morse
Publikováno v:
Cancer Research. 81:PS3-04
BACKGROUND: A majority of the 270,000 women diagnosed with breast cancer in the United States annually are candidates for breast conserving surgery (lumpectomy), however, up to 30% of patients require reoperation due to positive margins. The ideal re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ed5c8887900a61b4b286f8a9e451330
https://doi.org/10.1158/1538-7445.sabcs20-ps3-04
https://doi.org/10.1158/1538-7445.sabcs20-ps3-04